Comprehensive chemical characterization and biological evaluation of two Acacia species: A. nilotica and A. ataxacantha

2021 ◽  
pp. 112446
Author(s):  
Dimitrina Zheleva-Dimitrova ◽  
Kouadio Ibrahime Sinan ◽  
Ouattara Katinan Etienne ◽  
Gunes Ak ◽  
Jugreet B. Sharmeen ◽  
...  
2005 ◽  
Vol 48 (spe) ◽  
pp. 237-241 ◽  
Author(s):  
Daniel Granato ◽  
Domingos Sávio Nunes ◽  
Patrícia Póvoa de Mattos ◽  
Ester de Moura Rios ◽  
Adeline Glinski ◽  
...  

This study aimed chemical characterization and microbiological evaluation of extracts obtained from the waste of woods marketed in Paraná State: Peroba-Rosa (Aspidosperma sp.), Roxinho (Peltogyne sp.), Jatobá(Hymenaea sp.), Curupixá (Micropholis sp.), Itaúba (Mezilaurus sp.), Cedrilho (Erisma sp.) and Imbúia (Licaria sp.), whose botanical identifications were based on anatomical studies. The extracts were prepared with different solvents, analyzed by TLC and UV/VIS techniques, and tested against: Proteus mirabilis ATCC15290, Staphylococcus aureus ATCC25923, Escherichia coli ATCC25922, Enterobacter aerogenes ATCC13048, Micrococcus luteus ATCC9341, Klebsiella pneumoniae ATCC13883, Pseudomonas aeroginosa ATCC27853, Staphylococcus aureus, Streptococcus mutans and Bacillus cereus isolated from the clinic. The ethanol extract from Peroba-rosa containing alkaloids showed activity against P. mirabilis. Itaúba, Jatobá and Imbúia methanol extracts containing phenolics, and the Roxinho ethyl acetate extract containing terpenoids and phenolics were active against K. pneumoniae, M. luteus, E. coli, S. aureus and P. mirabilis. P. aeroginosa, S. mutans and E. aerogenes were resistant to the extracts.


2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Jamila Hedhli ◽  
Andrzej Czerwinski ◽  
Matthew Schuelke ◽  
Agata Płoska ◽  
Paweł Sowinski ◽  
...  

1999 ◽  
Vol 18 (4) ◽  
pp. 275-283 ◽  
Author(s):  
Sharon J. Northup

During the last 20 years, safety evaluation of medical devices has evolved from screening assays to the “pharmaceutical model” of preclinical testing. Biocompatibility testing guidelines for medical devices are published in the International Organization for Standardization (ISO) document 10993–1: Biological evaluation of medical devices—Part 1: Evaluation and testing. These guidelines are recognized by most national regulatory bodies and supplement, but do not supersede, the guidelines published by the individual nations or the testing requirements for a specific medical device. The ISO 10993 series includes screening tests for nonspecific mechanisms of toxicity (cytotoxicity, acute systemic toxicity, subchronic toxicity, local toxicity, and chronic toxicity) and specific mechanisms (blood compatibility, genotoxicity, carcinogenicity, pyrogenicity, and reproductive and developmental toxicity). Other ISO 10993 standards cover chemical characterization of materials, degradation products, toxicokinetics, sample preparation, permissible limits of sterilization and process residues, and clinical studies. This review examines the scope of these standards and identifies exceptions between these guidelines and selected national and vertical standards for medical devices.


2016 ◽  
Vol 4 (47) ◽  
pp. 7620-7629 ◽  
Author(s):  
E. Koziolová ◽  
D. Machová ◽  
R. Pola ◽  
O. Janoušková ◽  
P. Chytil ◽  
...  

We describe design, synthesis, physico-chemical characterization and preliminary biological evaluation of micelle-forming polymer drug conjugates with controlled drug release intended for tumor treatment.


2012 ◽  
Vol 8 (11) ◽  
pp. 874-885 ◽  
Author(s):  
Antonella Motta ◽  
Paola Segnana ◽  
Lucia Verin ◽  
Silvia La Monica ◽  
Claudia Fumarola ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document